Related Experiment Video
Updated: Jul 30, 2026
14:39
Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
Published on: April 21, 2014
Myocardial viability: recent developments in detection and clinical significance
1Section of Cardiology, Baylor College of Medicine, Houston, Texas 77030, USA.
Current Opinion in Cardiology
|October 5, 2001
Summary
Detecting myocardial viability is key for ischemic cardiomyopathy prognosis. Less fibrosis and higher thallium uptake indicate better recovery potential, guiding revascularization success.
Area of Science:
- Cardiology
- Medical Imaging
- Pathology
Background:
- Long-term prognosis in ischemic cardiomyopathy varies significantly.
- Left ventricular dysfunction results from scarred and hibernating myocardium.
- Fibrosis extent impacts functional recovery potential.
Purpose of the Study:
- To review recent advancements in detecting myocardial viability.
- To correlate myocardial structure with functional recovery after revascularization.
Main Methods:
- Echocardiography (low-dose dobutamine), nuclear cardiac imaging (thallium uptake), and magnetic resonance imaging (MRI) were discussed.
- Analysis of myocardial biopsies to assess fibrosis extent.
- Evaluation of contractile reserve and thallium uptake in hibernating myocardium.
Main Results:
- Segments with functional recovery showed more wall thickening, higher thallium uptake, and less fibrosis.
- Myocardial viability detected by dobutamine echocardiography correlated with less fibrosis and higher thallium uptake.
- Combined viability assessment (SPECT and DE) revealed significantly less fibrosis.
Conclusions:
- Myocardial fibrosis extent is a critical determinant of functional recovery in ischemic cardiomyopathy.
- Advanced imaging techniques improve the detection of myocardial viability.
- Accurate viability assessment guides revascularization strategies and patient prognosis.
More Related Videos
08:13In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
11:17A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury
Published on: November 28, 2025
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
01:27Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...